108 related articles for article (PubMed ID: 16755260)
1. Aspirin use and miscarriage risk.
Keim SA; Klebanoff MA
Epidemiology; 2006 Jul; 17(4):435-9. PubMed ID: 16755260
[TBL] [Abstract][Full Text] [Related]
2. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study.
Li DK; Liu L; Odouli R
BMJ; 2003 Aug; 327(7411):368. PubMed ID: 12919986
[TBL] [Abstract][Full Text] [Related]
3. Use of nonsteroidal antiinflammatory drugs during pregnancy and the risk of miscarriage.
Li DK; Ferber JR; Odouli R; Quesenberry C
Am J Obstet Gynecol; 2018 Sep; 219(3):275.e1-275.e8. PubMed ID: 29890124
[TBL] [Abstract][Full Text] [Related]
4. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study.
Nielsen GL; Sørensen HT; Larsen H; Pedersen L
BMJ; 2001 Feb; 322(7281):266-70. PubMed ID: 11157526
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
Glueck CJ; Sieve L; Zhu B; Wang P
Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy loss managed by cervical dilatation and curettage increases the risk of spontaneous preterm birth.
McCarthy FP; Khashan AS; North RA; Rahma MB; Walker JJ; Baker PN; Dekker G; Poston L; McCowan LM; O'Donoghue K; Kenny LC;
Hum Reprod; 2013 Dec; 28(12):3197-206. PubMed ID: 24052504
[TBL] [Abstract][Full Text] [Related]
7. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
Tempfer CB; Kurz C; Bentz EK; Unfried G; Walch K; Czizek U; Huber JC
Fertil Steril; 2006 Jul; 86(1):145-8. PubMed ID: 16716321
[TBL] [Abstract][Full Text] [Related]
8. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy.
Van Marter LJ; Leviton A; Allred EN; Pagano M; Sullivan KF; Cohen A; Epstein MF
Pediatrics; 1996 May; 97(5):658-63. PubMed ID: 8628603
[TBL] [Abstract][Full Text] [Related]
9. Risk of late first and second trimester miscarriage after induced abortion.
Bracken MB; Bryce-Buchanan C; Srisuphan W; Holford TR; Silten R
Am J Perinatol; 1986 Apr; 3(2):84-91. PubMed ID: 3964388
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for spontaneous abortion in early symptomatic first-trimester pregnancies.
Gracia CR; Sammel MD; Chittams J; Hummel AC; Shaunik A; Barnhart KT
Obstet Gynecol; 2005 Nov; 106(5 Pt 1):993-9. PubMed ID: 16260517
[TBL] [Abstract][Full Text] [Related]
11. Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure.
Daniel S; Koren G; Lunenfeld E; Levy A
Am J Obstet Gynecol; 2015 Mar; 212(3):307.e1-6. PubMed ID: 25265406
[TBL] [Abstract][Full Text] [Related]
12. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
[TBL] [Abstract][Full Text] [Related]
13. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.
Lanas A; Bajador E; Serrano P; Fuentes J; Carreño S; Guardia J; Sanz M; Montoro M; Sáinz R
N Engl J Med; 2000 Sep; 343(12):834-9. PubMed ID: 10995862
[TBL] [Abstract][Full Text] [Related]
14. Circulating chemokine levels and miscarriage.
Whitcomb BW; Schisterman EF; Klebanoff MA; Baumgarten M; Rhoton-Vlasak A; Luo X; Chegini N
Am J Epidemiol; 2007 Aug; 166(3):323-31. PubMed ID: 17504778
[TBL] [Abstract][Full Text] [Related]
15. PFOA and PFOS serum levels and miscarriage risk.
Darrow LA; Howards PP; Winquist A; Steenland K
Epidemiology; 2014 Jul; 25(4):505-12. PubMed ID: 24807698
[TBL] [Abstract][Full Text] [Related]
16. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
[TBL] [Abstract][Full Text] [Related]
17. Threatened miscarriage as a predictor of obstetric outcome.
Johns J; Jauniaux E
Obstet Gynecol; 2006 Apr; 107(4):845-50. PubMed ID: 16582121
[TBL] [Abstract][Full Text] [Related]
18. Risk of miscarriage in pregnant users of NSAIDs. More information is needed to be able to interpret study's results.
Chan LY; Yuen PM
BMJ; 2001 Jun; 322(7298):1365-6. PubMed ID: 11409400
[No Abstract] [Full Text] [Related]
19. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
Visser J; Ulander VM; Helmerhorst FM; Lampinen K; Morin-Papunen L; Bloemenkamp KW; Kaaja RJ
Thromb Haemost; 2011 Feb; 105(2):295-301. PubMed ID: 21103659
[TBL] [Abstract][Full Text] [Related]
20. Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure.
Winger EE; Reed JL
Am J Reprod Immunol; 2011 Oct; 66(4):320-8. PubMed ID: 21314851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
